Biorasi Completes Rare Nephrology Trial During COVID-19
Biorasi has completed subject visits under Part A in a rare disease nephropathy study during the peak of the COVID-19 outbreak.
30
06, 2020
By admin|2020-09-22T16:31:14+00:00June 30th, 2020|Tags: Clinical Trials, Covid19, Nephrology, Nephropathy, Virtual Trials|
Biorasi has completed subject visits under Part A in a rare disease nephropathy study during the peak of the COVID-19 outbreak.
